Other data have shown that CRP can predict outcomes in pancreatic neuroendocrine tumors, that preoperative elevated CRP represents a significant independent prognostic factor that predicts poor outcomes in cases undergoing curative resection for pancreatic ductal adenocarcinoma, and also that postoperative low serum CRP titers a week after resection were prognostic indicators of better survival [834,835]. Here, CRP is linked to pancreatic neuroendocrine tumor.